Amundi Asset Management US’s Insmed INSM Stock Holding History

Amundi Asset Management US’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$240K	Sell	7,036 -2,764	-28%	-$106K	﹤0.01%	1451
2020 Q4	$326K	Hold	9,800	–	–	﹤0.01%	1362
2020 Q3	$315K	Buy	9,800 +700	+8%	+$20.1K	﹤0.01%	1316
2020 Q2	$251K	Hold	9,100	–	–	﹤0.01%	1351
2020 Q1	$146K	Sell	9,100 -100	-1%	-$2.37K	﹤0.01%	1377
2019 Q4	$220K	Hold	9,200	–	–	﹤0.01%	1446
2019 Q3	$162K	Sell	9,200 -31,020,500	-100%	-$599M	﹤0.01%	1501
2019 Q2	$794M	Buy	31,029,700 +31,022,000	+402,883%	+$864M	0.65%	40
2019 Q1	$224K	Hold	7,700	–	–	﹤0.01%	1416
2018 Q4	$101	Buy	+7,700	New	+$123K	﹤0.01%	1511

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Amundi Asset Management US's INSM Position: Q1 2021 in Review

Amundi Asset Management US reduced its Insmed (INSM) stake by 28% in Q1 2021, selling an estimated $106K and leaving 7,036 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #1451.

Amundi Asset Management US first reported a position in INSM in Q4 2018 and has held it in 10 quarters since. The position peaked at $794M in Q2 2019. 198 funds tracked by Wall St. Rank hold INSM as of Q1 2021.

Amundi Asset Management US held 7,036 shares of Insmed worth $240K as of Q1 2021.
Amundi Asset Management US sold 2,764 Insmed shares in Q1 2021, an estimated $106K.
Insmed made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1451 holding.
Amundi Asset Management US first reported a position in Insmed in Q4 2018 and has held it in 10 quarters since.
Amundi Asset Management US's Insmed position peaked at $794M in Q2 2019.
198 funds tracked by Wall St. Rank held Insmed as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.